Combining the Power of PASV with CT Rated Ports...in tPA usage PASV T E C H N O L O G Y V A L V E...
Transcript of Combining the Power of PASV with CT Rated Ports...in tPA usage PASV T E C H N O L O G Y V A L V E...
Combining the Power of PASV with CT Rated Ports
Xcela* Plus Power-Injectable Portsare indicated up to 5mL/sec and 300 psi and are MRI-conditional—3 Tesla.
Plastic PortNon-Valved
Plastic Port withPASV Valve Technology
Titanium Port withPASV Valve Technology
Radiopaque under fluoroscopy
PASV Valve Technology designed to resist backflow, maintain patency, and provides a saline-only flushing option†
Flexible, kink-resistant catheter material
1/2” Septum diameterfor ease of port access
†Follow institution protocol
Multiple options designed to accommodate patient anatomy and clinical needs.[ [
PASV Valve Technology is Designed to:
The Power of PASVThe PASV* Valve Technology design automatically resists backflow,
reducing blood reflux that could lead to catheter-related complications.
Open for sampling and automatically close to resist pressure fluctuations that may cause blood reflux
Remain closed during normal increases in central venous pressure to prevent blood reflux in the catheter tip
Open with minimal pressure and automatically close after infusion
Reduced Complications†
(associated with catheter occlusion)Decreased Costs††
†Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA. A Prospective Randomized Trial Demonstrating Valved Implantable Ports Have Fewer Complications and Lower Overall Cost than Non-valved Implantable Ports. Am J Surg 2004;188:722-727. (Clinical data based on Vaxcel with PASV Port, a predicate to the Xcela Plus Port with PASV Valve Technology.)
†† Failure to achieve blood draw: non-valved=$480, valved=$303; $177 net savings per port. General maintenance costs: non-valved=$195, valved=$109; $86 net savings per port.Cost information based on Data from 2004.
39%reductionnet maintenance cost per port
Non-Valved Ports PASV Valve Technology Ports
n=73
6.7%
4.4%
10
5
0RATE
OF
OCC
LUSI
ON
(%)
n=73
1,545
750
0
1,000
2,000
NU
RSIN
G T
IME
(MIN
)
15
7
11%
n=73
5.8%
0INAB
ILIT
Y TO
DRA
W B
LOO
D (%
)
1,000
800
600
400
200
$675
n=73
$412
0TOTA
L CO
ST P
ER P
ATIE
NT
($)
Infusion Aspiration Closed
47% reduction in inadequate blood draws
51% reduction in troubleshooting time for nurses
35% reduction in tPA usage
PA S V
T
E C H N O L O G
Y
VA LVE
USA > 14 Plaza Drive, Latham, NY 12110 > tel: 800-772-6446 > fax: 518-798-1360 > Canada tel: 800-268-0184International > Haaksbergweg 75 (Margriettoren), 1101 BR, Amsterdam Z-O > The Netherlandstel: +31 (0)20 753 2949 > fax: +31 (0)20 753 2939
www.angiodynamics.com
*AngioDynamics, the AngioDynamics logo, Xcela, LifeGuard, PASV and Navilyst Medical are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or a subsidiary.
Manufacturer: Navilyst Medical, Inc., 26 Forest Street, Marlborough, MA 01752
XCELA PLUS POWER INJECTABLE PORTS
INTENDED USE/INDICATIONS FOR USE: The Xcela Plus Power Injectable Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, IV fluids, parenteral nutrition solutions, blood products and for the withdrawal of blood samples.
When used with a power injectable needle, the Xcela Plus Power Injectable Port is indicated for power injection of contrast media. For power injection of
contrast media, the maximum recommended infusion rate is 5 mL/sec with a 19 G or 20 G non-coring power injectable needle or 2 mL/sec with a 22 G non-coring power injectable needle.
CONTRAINDICATIONS: Inadequate body size to support device, bacteraemia, sepsis, known or suspected allergic response to materials, infection, peritonitis, past irradiation of prospective insertion site, previous episodes of venous thrombosis or vascular surgical procedures at the postoperative placement site, local
tissue factors will prevent proper device stabilization and/or access.
Refer to package insert provided with the product for complete Instructions for Use, Contraindications, Possible Complications, Warnings and Precautions prior to using this product.
CAUTION: Federal Law (USA) restricts this device for sale by or on the order of a physician.
Xcela Plus Power Injectable Ports
IMPORTANT RISK INFORMATION
Compatibility Options
Xcela Plus Power Injectable Ports are part of a complete portfolio of vascular access products, and are fully compatible with the LifeGuard* Safety Infusion Set.
Easily Identify Critical Information
• Radiopaque “CT” lettering confirms if port is power injectable or flipped
• Patient reminder band, ID card, key tag and record sticker provide added verification that the port is power injectable
© 2015 AngioDynamics, Inc. NAVB 440 NA Rev 3 08/15
Titanium Xcela Plus Port with PASV Valve Technology
Plastic Xcela Plus Port Non-Valved
UPN LumenCath Size
Suture Holes
Valved or Non-Valved
H965440290 Single 6F Non-Filled Non-Valved
H965440300 Single 6F Filled Non-Valved
H965440310 Single 8F Non-Filled Non-Valved
H965440320 Single 8F Filled Non-Valved
H965440370 Single 6F Non-Filled Valved
H965440380 Single 6F Filled Valved
H965440390 Single 8F Non-Filled Valved
H965440400 Single 8F Filled Valved
UPN LumenCath Size
Suture Holes
Valved or Non-Valved
H965440410 Single 6F Non-Filled Valved
H965440430 Single 8F Non-Filled Valved
Plastic Ports
Titanium Ports
XCELA PLUS PORT KITS INCLUDES: Port; Attachable catheter; Snaplocks (1); 18G Introducer needle; 0.038x 50cm J-guidewire; Valved introducer sheath; Metal tunneler; 17G Blunt needle; 22G Huber Needles: Straight (1), 90° (1); 12 mL Syringes: Slip (1), Luer (1); DFU & Patient Packet